Cardiac remodelling during pregnancy: whither the guinea pig? by Taggart MJ et al.
 Newcastle University ePrints 
 
Taggart MJ, Hume R, Lartey J, Johnson M, Tong W-C, Macleod KT.  
Cardiac remodelling during pregnancy: whither the guinea pig?. 
Cardiovascular Research 2014, 104(1), 226-227. 
 
Copyright: 
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Cardiology. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and 
reproduction in any medium, provided the original work is properly cited. 
DOI link to published article: 
http://dx.doi.org/10.1093/cvr/cvu198 




This work is licensed under a Creative Commons Attribution 4.0 International License 
 
 ePrints – Newcastle University ePrints 
http://eprint.ncl.ac.uk 
 
LETTER TO THE EDITOR
doi:10.1093/cvr/cvu198
Published online 25 August 2014
Cardiac remodelling during
pregnancy: whither the guinea
pig?
This letter refers to ‘Pregnancy
as a cardiac stress model’ by
E. Chung and L.A. Leinwand,
Cardiovascular Research
2014;101:561–570
We were interested to read the recent article
published by Chung and Leiwand1 entitled Preg-
nancy as a Cardiac Stress Model. This, and allied
articles in the Review Focus on Pregnancy-
mediatedHeart and Vascular Disease, eloquently
brought attention to an important, yet much
understudied, theme. Namely, that there is
much to be learnt from elucidating the remodel-
ling responses to the cardiovascular challenge of
pregnancy that may be beneficial to informing
our understanding of the sequence of events
leading to compensating cardiac hypertrophy
and the deleterious changes beyond those
which initiate and underpin progression to heart
failure.
Much of the experimental data reviewed
by Chung and Leiwand1 was derived from
mouse or rat models. This is understandable for
reasons of cost, accessibility, and ease of genetic
manipulation that facilitate mechanistic experi-
mentation in a timely fashion. An additional
important feature of the Chung and Leiwand1
article was to draw distinctions between
exercise-induced remodelling and pregnancy-
dependent adaptations, and the majority of
work in the former category has also been under-
taken in rat or mouse models. This therefore
offers a basis on which to compare the two
physiological remodelling circumstances.
Notwithstanding these benefits, one should
also recognizewhere limits reside for extrapolat-
ing information from mouse or rat models of
cardiac function in pregnancy to the human.
There are, to our minds, two issues of note.
First, the cardiac remodelling events occurring
in response to pregnancy are likely to be
mediated, in part, by changing levels of sex ster-
oidal hormones.1 Yet mice or rats differ from
humans in their mode of placentation, source of
steroidogenesis, circulating gestational hormone
levels, and the endocrine mechanism of partur-
ition onset.2 Secondly, the mouse or rat cardiac
ventricular action potential is considerably
shorter than that of the human. This complicates
Figure 1 Guinea pig pregnancy induces increased expression of cardiac ventricular ADBR1, INSR, and S1P1R. RNA samples were isolated from left
ventricles of non-pregnant and late pregnant (Day 68) guinea pig hearts (n ¼ 6); gene-specific quantitative PCR probes were designed for (A) ADRB1,
(B) INSR, and (C ) S1P1R by alignment with the Cavia porcellus genome5 and amplicons detected by SYBR green quantification. Results are expressed as
mean+ SEM fold change relative to a control RNA sample. Student’s t-test was used to test significance, *P, 0.05.
& The Author 2014. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse,
distribution, and reproduction in any medium, provided the original work is properly cited.







consideration of factors that may alter the shape
or duration of action potentials as is likely to
occur in conditions of hypertrophic cardiac
remodelling. Such factors are apt to change the
electrical characteristicsof themyocardium indif-
ferent areas and encourage arrhythmogenesis.
The relative roles played by the ionic currents
underlying the action potentials are subtly differ-
ent in rats/mice, and this makes extrapolations
to the human situation more challenging. The
systems linking the excitatory event to contrac-
tion [excitation-contraction (EC) coupling] also
differ from that in human. Mice and rat hearts
have very high gain EC coupling whereby a
relatively small Ca influx into each ventricular
myocyte triggers a much larger Ca release from
the sarcoplasmic reticulum (SR) that induces
contraction of the muscle cells. The system is
very dependent on having the SR well filled with
Ca almost to the point of overload, a factor in
itself that increases arrhythmogenicity in these
species. In turn, therefore, rat or mouse cardio-
myocyte relaxation occurs predominantly by
the sequestration of cytosolic Ca by the SR
Ca-ATPase with a much lesser contribution
from the sarcolemmal Na–Ca exchanger. The
balance of these Ca fluxes during contraction
and relaxation may be rather different in human
cardiac myocytes.2
Therefore, it would be of considerable benefit
to have an animal model that showed features of
pregnancy adaptations and cardiac EC coupling
that were similar to the human situation. We
suggest that someof these issues canbe improved
by considering the use of guinea pigs to study
cardiac function inpregnancy.The formof placen-
tation, levels of circulating steroids during preg-
nancy, the lack of maternal progesterone
withdrawal preceding parturition, the shape of
the ventricular cardiac action potentials, and the
balance of Ca fluxes underlying contraction and
relaxation in the guinea pig are each more
similar to the human situation than mice or
rats.3 Indeed, Chung and Leiwand1 refer to
important work from the 1980s in non-pregnant
guinea pigs, whereby oestradiol infusion to non-
pregnant guinea pigs resulted in similar cardiovas-
cular changes to that arising frompregnancy.4This
once popular model of the pregnant guinea pig
has fallen out of favour probably as a result of
(i) efforts in the post-genomic age being directed
towardsmolecular andphysiological phenotyping
inmice and (ii) theperceiveddifficulty in accurate-
ly time-mating guinea pigs due to their rather
long oestrous cycle of 20 days. The latter
issue we have overcome by daily observance of
animals such that we can time-mate guinea pigs,
to within 24 h, and achieve 90% pregnancy
success. In addition, the guinea pig genome
has been sequenced.5 Consequently, we have
begun to explore the molecular changes taking
place in guinea pig heart during pregnancy and
compare the left-ventricular transcriptional pro-
files between late pregnancy and non-pregnancy.
In particular, we have noted increases in the ex-
pression of genes encoding several molecules
thatmay impact upon growth and/or ECcoupling.
These include the b1 adrenoceptor (ADRB1), as
well as the insulin receptor (INSR) and the S1P1
receptor (S1P1R) (Figure 1). Of note, in the
guinea pig, continued b1 adrenoceptor stimula-
tion results in cardiac hypertrophy.6 Thus, our
preliminary data suggest that the remodelling
responses to pregnancy may be similar to the, ini-
tially beneficial, adaptive responses taking place in
cardiac tissue in response to pathological insult
which can, in time, tip over into detrimental
changes leading to heart failure. As commented
by Chung and Leiwand,1 a feature of hearts late
in pregnancy is that they may be operating on
this edge of dysfunction. If so, then exploring the
functional impact on EC coupling of such preg-
nancy-related molecular changes may reveal im-
portant clues for the future prevention and/or
treatment of failing hearts.
In summary, we add our support to the
suggestion1 that the physiological cardiovascular
remodelling of pregnancy offers a valuable situ-
ation, of scientific and clinical importance, from
which we can gain insights for our understanding
of, and possibly treatment for, many situations of
pathological remodelling leading to heart failure.
To do so with optimum impact requires us to
collate data from a number of experimental
animal models, accepting the limitations and
benefits of each, for relevance to the human
condition. As such, we suggest that the adoption
of the pregnant guinea pig will provide additional
valuable information for these considerations.
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